Immunological priming of mesenchymal stromal/stem cells and their extracellular vesicles augments their therapeutic benefits in experimental graft-versus-host disease via engagement of PD-1 ligands

Mesenchymal stromal cells (MSCs) and their extracellular vesicles (EVs) exert profound anti-inflammatory and regenerative effects in inflammation and tissue damage, which makes them an attractive tool for cellular therapies. In this study we have assessed the inducible immunoregulatory properties of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hackel, Alexander, Vollmer, Sebastian, Bruderek, Kirsten, Lang, Stephan, Brandau, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978482/
https://www.ncbi.nlm.nih.gov/pubmed/36875112
http://dx.doi.org/10.3389/fimmu.2023.1078551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978482/
https://www.ncbi.nlm.nih.gov/pubmed/36875112
http://dx.doi.org/10.3389/fimmu.2023.1078551

Ejemplares similares